Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Poor earning updates keep European shares at 12-day low

Published 11/13/2017, 04:49 AM
© Reuters. The German share price index, DAX board, is seen at the stock exchange in Frankfurt

By Danilo Masoni

MILAN (Reuters) - Heavy losses in utility EDF (PA:EDF) after a profit warning and other disappointing company updates weighed on European shares on Monday, while a weaker pound helped the FTSE outperform.

EDF fell 8 percent, leading losers on the STOXX 600 (STOXX) and helping push the pan-European benchmark index down 0.4 percent by 0934 GMT to its lowest since Oct. 26.

The French group lowered its 2018 earnings and cash flow forecasts due to lower than expected power consumption, lower availability of some of its nuclear reactors in early 2018 and a drop in capacity compensation in Britain.

Exane BNP Paribas (PA:BNPP) affirmed its underperform rating on EDF.

"The market is overly focused on the power price strength and not reflecting appropriately all the other issues facing the group, including the fact that if nuclear output falls short of expectations, higher power prices are actually a negative for them," it said in an email to clients.

Sonova (S:SOON) was another leading faller, down 6.6 percent.

The Swiss hearing aid maker reported first-half results that fell short of analyst expectations, as sales in the U.S. were dented by an overhaul of the company's retail network there.

According to Thomson Reuters IBES data, about 76 percent of MSCI EMU companies have reported earnings so far, with 50 percent of them beating expectations. That compares to 72 percent for the S&P 500 and 54 percent for the broader MSCI Europe index.

Losses in EDF and Sonova were partly offset by gains in pharma heavyweight Novartis (S:NOVN).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Its shares rose 1 percent after data showed that patients on its new eye-drug showed less disease activity than those on its rivals Bayer's (DE:BAYGn) and Regeneron's (O:REGN) drug. Bayer was down 0.4 percent

The broader market was also supported by gains in the FTSE, which rose 0.3 percent, buoyed by gains in big export-oriented including Diageo (L:DGE) and Shire (L:SHP). They found support in falls in the pound following press reports of a building parliamentary mutiny against Prime Minister Theresa May..

The top faller on the FTSE was Coca-Cola HBC (L:CCH), down 5.9 percent, following a downgrade to neutral from JP Morgan.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.